 |
|
Ambulatory Gynecology
Jeffrey F. Peipert, MD, MPH
JAMA. 2000;283:2630-2632.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
In ambulatory gynecology and the primary care of women, there are few preventive services that pass a careful evidence-based assessment of effectiveness. A relatively small percentage (<15%) of the screening and counseling interventions evaluated by the US Preventive Services Task Force received an "A" recommendation.1 The Papanicolaou test is one example of an "A" recommendation from the task force as an effective preventive service in women's health. Chemoprophylaxis, the use of chemicals or medications to prevent the occurrence of a disease, is another strategy for prevention. An excellent example of effective chemoprophylaxis in women's health is the use of emergency contraception to prevent unintended pregnancy. Recent advances in emergency contraception and Papanicolaou test technology have changed the practice patterns in many clinical centers. This update of ambulatory gynecology will provide an assessment of the state-of-the-science for these 2 areas and will also describe some recent . . . [Full Text of this Article]
Advances in Emergency Contraception
Cervical Cytologic (Papanicolaou Test) Screening
Bacterial Vaginosis and Complications in Obstetrics and Gynecology
Conclusion
Author Affiliations: Division of Research in Women's Health, Department of Obstetrics, Gynecology and Community Health, Women and Infants' Hospital, Brown University School of Medicine, Providence, RI.
RELATED ARTICLE
May 24, 2000
JAMA. 2000;283(20):2729-2730.
EXTRACT
| FULL TEXT
|
